1. Home
  2. NRXP vs ZCMD Comparison

NRXP vs ZCMD Comparison

Compare NRXP & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • ZCMD
  • Stock Information
  • Founded
  • NRXP 2015
  • ZCMD 2012
  • Country
  • NRXP United States
  • ZCMD China
  • Employees
  • NRXP N/A
  • ZCMD N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • NRXP Health Care
  • ZCMD Real Estate
  • Exchange
  • NRXP Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • NRXP 32.6M
  • ZCMD 29.0M
  • IPO Year
  • NRXP N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • NRXP $3.38
  • ZCMD $1.22
  • Analyst Decision
  • NRXP Strong Buy
  • ZCMD
  • Analyst Count
  • NRXP 4
  • ZCMD 0
  • Target Price
  • NRXP $28.50
  • ZCMD N/A
  • AVG Volume (30 Days)
  • NRXP 267.4K
  • ZCMD 650.7K
  • Earning Date
  • NRXP 08-13-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • NRXP N/A
  • ZCMD N/A
  • EPS Growth
  • NRXP N/A
  • ZCMD N/A
  • EPS
  • NRXP N/A
  • ZCMD N/A
  • Revenue
  • NRXP N/A
  • ZCMD $15,864,773.00
  • Revenue This Year
  • NRXP N/A
  • ZCMD N/A
  • Revenue Next Year
  • NRXP N/A
  • ZCMD N/A
  • P/E Ratio
  • NRXP N/A
  • ZCMD N/A
  • Revenue Growth
  • NRXP N/A
  • ZCMD N/A
  • 52 Week Low
  • NRXP $1.10
  • ZCMD $0.95
  • 52 Week High
  • NRXP $6.01
  • ZCMD $2.97
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 58.54
  • ZCMD 51.29
  • Support Level
  • NRXP $2.90
  • ZCMD $1.12
  • Resistance Level
  • NRXP $3.53
  • ZCMD $1.30
  • Average True Range (ATR)
  • NRXP 0.20
  • ZCMD 0.14
  • MACD
  • NRXP -0.03
  • ZCMD -0.01
  • Stochastic Oscillator
  • NRXP 76.19
  • ZCMD 35.26

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: